Abstract
Asthma and obesity are two common disorders often associated in children and characterized by an inflammatory status. Growing evidences support a connection between obesity and asthma since weight reduction can improve asthmatic symptoms.
In this study, we have enrolled eighty children: 17 non asthmatics and non obese, 19 obese, 28 asthmatics-obese and, 16 asthmatics non-obese, respectively. In all participants, respiratory functional tests and body mass index (BMI) were calculated. Moreover, systemic inflammation of biomarkers such as T helper (h)1-type, Th2-type and T regulatory-type serum cytokines along with major adipokines was determined.
Data will show that the association between asthma and obesity leads to a predominant Th1-type response with an increase in pro-inflammatory cytokines. This inflammatory profile in asthmatics-obese children is sustained by elevated serum levels of leptin and visfatin, while adiponectin concentration is rather diminished.
Finally, levels of systemic inflammatory biomarkers positively correlate with the increase in BMI values in all population subgroups.
Keywords: Adiponectin, adipose tissue, asthma, children, cytokine, leptin, obesity, resistin, visfatin.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Characterization of the Immune Inflammatory Profile in Obese Asthmatic Children
Volume: 14 Issue: 3
Author(s): Thea Magrone, Maria Simone, Luigi Mappa, Riccardina Tesse, Paola Giordano, Maria Altamura and Irene Munno
Affiliation:
Keywords: Adiponectin, adipose tissue, asthma, children, cytokine, leptin, obesity, resistin, visfatin.
Abstract: Asthma and obesity are two common disorders often associated in children and characterized by an inflammatory status. Growing evidences support a connection between obesity and asthma since weight reduction can improve asthmatic symptoms.
In this study, we have enrolled eighty children: 17 non asthmatics and non obese, 19 obese, 28 asthmatics-obese and, 16 asthmatics non-obese, respectively. In all participants, respiratory functional tests and body mass index (BMI) were calculated. Moreover, systemic inflammation of biomarkers such as T helper (h)1-type, Th2-type and T regulatory-type serum cytokines along with major adipokines was determined.
Data will show that the association between asthma and obesity leads to a predominant Th1-type response with an increase in pro-inflammatory cytokines. This inflammatory profile in asthmatics-obese children is sustained by elevated serum levels of leptin and visfatin, while adiponectin concentration is rather diminished.
Finally, levels of systemic inflammatory biomarkers positively correlate with the increase in BMI values in all population subgroups.
Export Options
About this article
Cite this article as:
Magrone Thea, Simone Maria, Mappa Luigi, Tesse Riccardina, Giordano Paola, Altamura Maria and Munno Irene, Characterization of the Immune Inflammatory Profile in Obese Asthmatic Children, Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14 (3) . https://dx.doi.org/10.2174/1871530314666140526095211
DOI https://dx.doi.org/10.2174/1871530314666140526095211 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Characterization of a Novel Polysaccharide-Iron(III) Complex and Its Anti-Anemia and Nonspecific Immune Regulating Activities
Mini-Reviews in Medicinal Chemistry Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism Ascaris lumbricoides: An Overview of Therapeutic Targets
Infectious Disorders - Drug Targets Challenges in the Management of Severe Asthma: Role of Current and Future Therapies
Current Pharmaceutical Design Structure-Based Rational Design of Adenosine Receptor Ligands
Current Topics in Medicinal Chemistry Neutrophil to Lymphocyte (N/L) and Platelet to Lymphocyte (P/L) Ratios in Differentiating Acute Heart Failure from Respiratory Infection
Current Vascular Pharmacology The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets Prospects for miR-21 as a Target in the Treatment of Lung Diseases
Current Pharmaceutical Design Protein Kinase A (PKA) - A Potential Target for Therapeutic Intervention of Dysfunctional Immune Cells
Current Drug Targets Does Metformin Satisfy as an Option for Host-Directed Therapy in COVID-19?
Anti-Infective Agents An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases
Current Respiratory Medicine Reviews Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis
Anti-Cancer Agents in Medicinal Chemistry Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Parvalbumin as a Pleomorphic Protein
Current Protein & Peptide Science Signal Transduction Pathways of Inflammatory Gene Expressions and Therapeutic Implications
Current Pharmaceutical Design Reintroduction of Cow’s Milk in Milk-Allergic Children
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of IL-17F in the Pathogenesis of Psoriasis
Current Immunology Reviews (Discontinued) Nanoparticle-Based Therapy in Genomics
Current Drug Metabolism Emerging Nanonisation Technologies: Tailoring Crystalline Versus Amorphous Nanomaterials
Current Topics in Medicinal Chemistry CCR1 Antagonists: What Have We Learned From Clinical Trials
Current Topics in Medicinal Chemistry